Culprit vessel revascularization first with primary use of a dedicated transradial guiding catheter to reduce door to balloon time in primary percutaneous coronary intervention

Jincheng Guo, Guozhong Wang, Zixuan Li, Zijing Liu, Yujie Wang, Senhu Wang, Yuntao Wang, Yongxia Wu, Haotian Wang, Yuping Wang, Libin Zhang, Qi HuaFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

This study investigated a novel approach to primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) by using a single transradial guiding catheter (STGC) for immediate culprit vessel revascularization. The findings demonstrate that this strategy significantly reduces door-to-balloon (D2B) time, catheterization laboratory door-to-balloon (C2B) time, procedural time, and fluoroscopy time, while also decreasing radial artery perforation rates, without compromising clinical outcomes.

What Problem Does This Paper Address?

In patients experiencing ST-elevation myocardial infarction (STEMI), rapid restoration of blood flow to the blocked coronary artery is critical to minimize heart muscle damage and improve survival. The "door-to-balloon" (D2B) time, the interval from hospital arrival to the inflation of a balloon in the culprit artery, is a key performance metric for primary PCI. While radial access (through the wrist) is preferred over femoral access (through the groin) due to lower complication rates, it can sometimes lead to longer D2B times. This paper addresses the challenge of optimizing D2B time in STEMI patients undergoing primary PCI, specifically by exploring whether a streamlined approach using a single guiding catheter for both initial angiography and subsequent intervention via the radial artery can be more efficient than the traditional method of performing a complete diagnostic angiography first, followed by selecting a separate guiding catheter for intervention.

Methods

This was a prospective, randomized, controlled, single-center study (RAPID II trial) involving 560 STEMI patients undergoing primary PCI. Patients were randomized into two groups:

  • STGC Group (n=280): Underwent electrocardiogram (ECG)-guided immediate intervention on the culprit vessel using a dedicated transradial guiding catheter (6F MAC3.5 or JL3.5). Contralateral angiography was performed using the same catheter afterward.
  • Control Group (n=280): Underwent complete coronary angiography using a universal diagnostic catheter (5F Tiger II), followed by selection of a guiding catheter for culprit vessel PCI.

The primary endpoint was D2B time. Secondary endpoints included catheterization laboratory door-to-balloon (C2B) time, procedural time, fluoroscopy time, and major adverse cardiac events (MACE) at 30 days.

Datasets

Not discussed in the paper. The study utilized data collected from 560 patients enrolled in the RAPID II trial.

Key Insights and Ideas

  • Streamlining Catheter Use is Key: The core idea is that by using a single, specialized guiding catheter for the entire procedure (or at least the initial stages), the need for catheter exchanges can be minimized, directly impacting procedural efficiency.
  • Efficiency Gains Beyond D2B: While D2B time is the primary focus, the study highlights that this streamlined approach also leads to significant reductions in C2B, procedural, and fluoroscopy times. This suggests a broader impact on resource utilization and operator workload.
  • Reduced Complications with STGC: The finding that radial artery perforation (RAP) was significantly lower in the STGC group is a crucial safety insight, suggesting that the dedicated STGC might be less traumatic to the radial artery compared to multiple catheter manipulations.
  • Clinical Equivalence: Importantly, the efficiency gains did not come at the cost of patient safety or outcomes, as MACE at 30 days was similar between the groups.

Key Results

  • Shorter D2B Time: The median D2B time was significantly shorter in the STGC group (53.9 min) compared to the control group (58.4 min) (p = 0.003).
  • Reduced C2B, Procedural, and Fluoroscopy Times:
    • C2B time: 17.3 min (STGC) vs. 24.5 min (Control) (p < 0.001)
    • Procedural time: 45.2 min (STGC) vs. 49.0 min (Control) (p = 0.012)
    • Fluoroscopy time: 9.7 min (STGC) vs. 11.3 min (Control) (p = 0.025)
  • Higher Achievement of Time Goals: More patients in the STGC group achieved D2B times within 90 minutes (93.9% vs. 87.1%, p = 0.006) and 60 minutes (61.4% vs. 51.1%, p = 0.013).
  • Lower Radial Artery Perforation (RAP): The rate of RAP was significantly lower in the STGC group (0.7%) compared to the control group (3.2%) (p = 0.033).
  • Similar MACE: Major adverse cardiac events (MACE) at 30 days were comparable between the groups (2.5% in STGC vs. 4.6% in control, p = 0.172).

Limitations and Future Work

The authors acknowledge several limitations:

  • Open-Label Trial: The study was open-label, which could introduce bias.
  • Single-Center Study: Conducted at a high-volume tertiary center, results may not be generalizable to lower-volume centers.
  • Default Radial Access: The study primarily used the right radial artery, and the applicability of the STGC technique to left radial access needs further investigation.
  • Primary Endpoint: The primary endpoint was D2B time, not clinical outcomes, limiting direct conclusions on long-term patient benefit from the time savings alone.
  • Medication Availability: Prasugrel was not available in China, and ticagrelor use was moderate, potentially reflecting therapeutic inertia.
  • Patient Demographics: A high proportion of male patients may limit generalizability.
  • Aspiration Thrombectomy and AF: High rates of aspiration thrombectomy and low incidence of AF were noted, which could influence interpretation.
  • Short Follow-up: The follow-up duration was relatively short.

Future work should focus on evaluating the long-term clinical outcomes of this strategy and further investigating its applicability in different patient populations and settings. The authors also suggest that further studies are required to evaluate the effects of this strategy on clinical outcomes.

Summary updated

Abstract

ECG-guided immediate intervention on culprit vessel with a STGC can reduce D2B, C2B, procedural, and fluoroscopy times (ECG-guided Immediate Primary PCI for Culprit Vessel to Reduce Door to Device Time; NCT03272451).
BibTeX
@inproceedings{guo2022culprit,
  author = {Jincheng Guo and Guozhong Wang and Zixuan Li and Zijing Liu and Yujie Wang and Senhu Wang and Yuntao Wang and Yongxia Wu and Haotian Wang and Yuping Wang and Libin Zhang and Qi Hua},
  title = {{Culprit vessel revascularization first with primary use of a dedicated transradial guiding catheter to reduce door to balloon time in primary percutaneous coronary intervention}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2022.1022488},
}
Figure